NCT04937556View on ClinicalTrials.gov

Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19 (Coronavirus Disease).

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

March 25, 2022

Study Completion Date

April 30, 2022

Conditions
Covid19
Interventions
DIETARY_SUPPLEMENT

Probiotic: Lactobacillus salivarius + Vit D + Zinc

A mixture of 1\*10E9 colony forming unit (CFU) of Lactobacillus salivarius + Vit D + Zinc citrate in 1 capsule will be daily administrated during 28 days.

DIETARY_SUPPLEMENT

Placebo

Placebo in 1 capsule will be daily administrated during 28 days.

Trial Locations (1)

Unknown

Hospital Universitario Infanta Leonor, Madrid

All Listed Sponsors
lead

ProbiSearch SL

INDUSTRY

NCT04937556 - Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19 (Coronavirus Disease). | Biotech Hunter | Biotech Hunter